TA303 Multiple sclerosis (relapsing) - teriflunomide: press release information
History
A list of downloadable documents created during development.
Background information
Multiple sclerosis (relapsing) - teriflunomide: equality impact assessment - guidance review
Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination
-
Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination information
-
Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination (PDF 218 KB)
-
Multiple sclerosis (relapsing) - teriflunomide: evaluation report information
-
Multiple sclerosis (relapsing) - teriflunomide: evaluation report (PDF 1.84 MB)
Multiple sclerosis (relapsing) - teriflunomide: appraisal consultation
-
Multiple sclerosis (relapsing) - teriflunomide: appraisal consultation
-
Multiple sclerosis (relapsing) - teriflunomide: appraisal consultation document information
-
Multiple sclerosis (relapsing) - teriflunomide: evaluation report information
-
Multiple sclerosis (relapsing) - teriflunomide: evaluation report (PDF 12.56 MB)